|
Jun 20
|
Incyte (INCY) Teams Up with QIAGEN to Boost Blood Cancer Diagnostic Solutions
|
|
Jun 20
|
Here's Why Qiagen (QGEN) is a Strong Growth Stock
|
|
Jun 15
|
QIAGEN and Incyte Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expressing Myeloproliferative Neoplasms (MPNs)
|
|
Jun 13
|
Should You Add QIAGEN Stock to Your Portfolio for Now?
|
|
Jun 11
|
Can Hologic Lean on Its Strengths in a Tough Macroeconomic Climate?
|
|
May 25
|
Qiagen and ID Solutions Partner to Enhance Digital PCR Assays for Oncology Research
|
|
May 23
|
QGEN Stock Might Gain Following New Partnership With ID Solutions
|
|
May 23
|
Qiagen and ID Solutions collaborate on dPCR assays for oncology research
|
|
May 22
|
QIAGEN expands digital PCR oncology research portfolio through partnership with ID Solutions
|
|
Apr 16
|
Why Qiagen (QGEN) is a Top Momentum Stock for the Long-Term
|
|
Apr 15
|
Qiagen Plans 3 New Sample Preparation Instrument Launches Through 2026
|
|
Apr 15
|
QIAGEN Advancing Plans to Launch Three New Sample Preparation Instruments by 2026 to Improve Lab Automation
|
|
Apr 10
|
Biogen (BIIB) Soars 5.7%: Is Further Upside Left in the Stock?
|
|
Apr 8
|
QIAGEN N.V. to Release Results for Q1 2025 and Hold Webcast
|
|
Mar 12
|
Is it Worth Retaining QIAGEN Stock in Your Portfolio Now?
|
|
Mar 3
|
Qiagen N.V. (QGEN): Among the Cash-Rich Mid Cap Stocks to Buy Now
|
|
Mar 3
|
QIAGEN takes legal action to defend QuantiFERON intellectual property and protect innovations in latent tuberculosis testing
|
|
Feb 23
|
2 Recent Stock Splits You've Never Heard of That Certain Wall Street Analysts Think Could Soar 39% and 62%
|
|
Feb 14
|
Institutional owners may take dramatic actions as Qiagen N.V.'s (NYSE:QGEN) recent 5.6% drop adds to one-year losses
|
|
Feb 13
|
QIAGEN Strengthens Global Bioinformatics Leadership With New Data Center in Australia/Asia-Pacific Region
|